proadifen has been researched along with charybdotoxin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, K; Fujii, H; Honda, H; Kanazawa, M; Kogo, H; Moroe, H; Notoya, Y | 1 |
Chi, BR; Liu, Q; Zhao, HY | 1 |
Castro-Chaves, P; Fontes-Carvalho, R; Leite-Moreira, AF; Soares, S | 1 |
3 other study(ies) available for proadifen and charybdotoxin
Article | Year |
---|---|
Characterization of endothelium-dependent relaxation and modulation by treatment with pioglitazone in the hypercholesterolemic rabbit renal artery.
Topics: Animals; Biological Factors; Charybdotoxin; Endothelium, Vascular; Enzyme Inhibitors; Hypercholesterolemia; Hypoglycemic Agents; Indomethacin; Male; Nitroarginine; Pioglitazone; Potassium Channel Blockers; Proadifen; Rabbits; Renal Artery; Tetraethylammonium; Thiazolidinediones; Time Factors; Vasodilation | 2004 |
[Role of endothelium-derived hyperpolarizing factor in shear stress-induced endothelium-dependent relaxations of rats].
Topics: Animals; Apamin; Biological Factors; Charybdotoxin; Cytochrome P-450 Enzyme Inhibitors; Endothelium, Vascular; In Vitro Techniques; Large-Conductance Calcium-Activated Potassium Channels; Male; Mesenteric Arteries; Nitric Oxide; Potassium Channel Blockers; Proadifen; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Small-Conductance Calcium-Activated Potassium Channels; Vasodilation | 2005 |
Negative inotropic effect of selective AT2 receptor stimulation and its modulation by the endocardial endothelium.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apamin; Bradykinin; Cardiovascular Agents; Charybdotoxin; Cyclooxygenase Inhibitors; Depression, Chemical; Dose-Response Relationship, Drug; Endocardium; Endothelial Cells; Enzyme Inhibitors; Hydroxocobalamin; Imidazoles; In Vitro Techniques; Indomethacin; Myocardial Contraction; Naphthyridines; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Papillary Muscles; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Proadifen; Pyridines; Rabbits; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Time Factors | 2008 |